Antimalarial Drug Research and Development

Antimalarial Drug Research and Development - Pharmacology - Research, Safety Testing and Regulation

Hardback (07 Feb 2014)

Not available for sale

Includes delivery to the United States

Out of stock

This service is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Publisher's Synopsis

Malaria-like febrile illnesses have been described since Hippocrates as fevers that were periodic and associated with marshes and swamps. The word "malaria" comes from the Italian "mal'aria" for "bad airs". Malaria is transmitted to humans via the bite of the infected female mosquito of anopheles species. Malaria can exist, in a mild form that is most commonly associated with flu-like symptoms; fever, vomiting, and general malaise. Most disease cases are found in the poorest countries; tropical Africa, Latin America, Southern Asia and Oceania. More concern is being given now to malaria even in countries where there is a low risk of infection due to the phenomena of global warming which is significantly increasing. In this book, the authors present current research in the study of anti-malarial drug research and developments. Topics discussed in this compilation include the anti-malarial atovaquone prodrugs based on enzyme models with molecular orbital calculations approach; new quinoline-based multiple ligands in antimalarial drug development; new molecular scaffolds as potential therapeutic agents to combat antimalarial resistance; and PfCRT mediates sensitivity of chloroquine-resistant P Falciparum to diamidines.

Book information

ISBN: 9781629482088
Publisher: Nova Science Publishers, Inc
Imprint: Nova Science Publishers
Pub date:
DEWEY: 616.93620610724
DEWEY edition: 23
Language: English
Number of pages: ix, 233
Weight: 474g
Height: 229mm
Width: 157mm
Spine width: 19mm